PAVmed Inc. — Director's Dealing 2018

Jul 12, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2018-06-26

Reporting Person: DeGuzman Brian J. (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-26	Series Z Warrants	$1.60	J	322673	Acquired	2024-04-30	Common Stock (322673)	Indirect
2018-06-26	Series Z Warrants	$1.60	J	322673	Disposed	2024-04-30	Common Stock (322673)	Indirect

Footnotes

F1: Pro rata distribution from HCFP/Capital Partners III LLC, of which the trust is a non-managing member.

F2: Contribution to Pavilion Venture Partners LLC, of which the trust is a non-managing member.